Insider Trading & Ownership of Motif Pharmaceuticals Ltd.

Location: Dublin, Ireland
Summary: The estimated value of insider holdings of Motif Pharmaceuticals Ltd. is at least $442,434 dollars as of 15 Feb 2024. Motif Pharmaceuticals Ltd. is the 10%+ Owner of Chromocell Therapeutics Corp and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $442.4K.
Signature: Motif Pharmaceuticals Ltd., By /s/ Zachary Klein
All Insider Reports: All Insider Reports

Notify me when Motif Pharmaceuticals Ltd. files a new Insider Trading report.

Ownership of Motif Pharmaceuticals Ltd.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
PTHS	Chromocell Therapeutics Corp	10%+ Owner	$442,434			15 Feb 2024